Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants
Open Access
- 24 January 2018
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 32 (2) , 191-203
Abstract
Regulators of G protein signaling are proteins that accelerate the termination of effector stimulation after G protein-coupled receptor activation. Many regulators of G protein signaling proteins are highly expressed in the brain and therefore considered potential drug discovery targets for central nervous system pathologies; for example, here we show that RGS12 is highly expressed in microdissected mouse ventral striatum. Given a role for the ventral striatum in psychostimulant-induced locomotor activity, we tested whether Rgs12 genetic ablation affected behavioral responses to amphetamine and cocaine. RGS12 loss significantly decreased hyperlocomotion to lower doses of both amphetamine and cocaine; however, other outcomes of administration (sensitization and conditioned place preference) were unaffected, suggesting that RGS12 does not function in support of the rewarding properties of these psychostimulants. To test whether observed response changes upon RGS12 loss were caused by changes to dopamine transporter expression and/or function, we prepared crude membranes from the brains of wild-type and RGS12-null mice and measured dopamine transporter-selective [3H]WIN 35428 binding, revealing an increase in dopamine transporter levels in the ventral–but not dorsal–striatum of RGS12-null mice. To address dopamine transporter function, we prepared striatal synaptosomes and measured [3H]dopamine uptake. Consistent with increased [3H]WIN 35428 binding, dopamine transporter-specific [3H]dopamine uptake in RGS12-null ventral striatal synaptosomes was found to be increased. Decreased amphetamine-induced locomotor activity and increased [3H]WIN 35428 binding were recapitulated with an independent RGS12-null mouse strain. Thus, we propose that RGS12 regulates dopamine transporter expression and function in the ventral striatum, affecting amphetamine- and cocaine-induced increases in dopamine levels that specifically elicit acute hyperlocomotor responses.Keywords
This publication has 67 references indexed in Scilit:
- Tyrosine hydroxylase and regulation of dopamine synthesisArchives of Biochemistry and Biophysics, 2011
- Stimulant Abuse: Pharmacology, Cocaine, Methamphetamine, Treatment, Attempts at PharmacotherapyPrimary Care: Clinics in Office Practice, 2011
- How Addictive Drugs Disrupt Presynaptic Dopamine NeurotransmissionNeuron, 2011
- RGS14 is a natural suppressor of both synaptic plasticity in CA2 neurons and hippocampal-based learning and memoryProceedings of the National Academy of Sciences, 2010
- Neuroplasticity in the mesolimbic dopamine system and cocaine addictionBritish Journal of Pharmacology, 2008
- Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporterProceedings of the National Academy of Sciences, 2008
- C57BL/6J mice show greater amphetamine-induced locomotor activation and dopamine efflux in the striatum than 129S2/SvHsd micePharmacology Biochemistry and Behavior, 2007
- Selective role for RGS12 as a Ras/Raf/MEK scaffold in nerve growth factor‐mediated differentiationThe EMBO Journal, 2007
- Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporterProceedings of the National Academy of Sciences, 2006
- Regulators of G-Protein signalling as new central nervous system drug targetsNature Reviews Drug Discovery, 2002